Blockade of NKG2D prevented diabetes development and progression in previous studies [66, 67], suggesting that it might suppress the function of pathogenic NKT1 cells and promote regulatory type 2/17 NKT cells. This evidence concerns the gene KLRK1 and diabetes mellitus.